RNF6 and cancer: Additionally, RNF6 is silenced, which increases GSK3 activity, decreases p-GSK3 inhibition of the Wnt/β-Catenin pathway in cancer cells, and suppresses MAPK/ERK signaling, which in turn reduces cell growth and proliferation [90,91].